skip navigation nih record
Vol. LVIII, No. 22
November 03, 2006

previous story

next story

NIMH Series Examines Innovative Thinking

There are seven lectures remaining in the NIMH Director’s Innovation Speaker Series. All lectures are in conference rooms C and D, Neuroscience Center, 6001 Executive Blvd., at 3 p.m. In the talks, scientists will describe how they crossed traditional boundaries to successfully develop ideas. The speakers have worked in academia, industry and global health policy. The audience is encouraged to join discussions.

Nov. 28—Dr. Karl Deisseroth is launching an effort to map key neural-circuit dynamics on a millisecond scale, using his NIH Director’s Pioneer Award. The Stanford University faculty member hopes to contribute to new conceptualizations of neurological and psychiatric disorders and circuit- modulation interventions for treatment of disease.

Dec. 11—Dr. Martin E.P. Seligman is widely known for his groundbreaking early work on the “learned helplessness” model of depression. He is considered a major contributor to contemporary models of cognitive psychotherapies and is the Fox leadership professor of psychology, University of Pennsylvania and past president of the American Psychological Association.

Jan. 22, 2007—Dr. Sonja K. Schoenwald leads a successful effort to transport an evidence-based treatment—multisystem therapy for high-risk youth—into wider use through innovative partnerships with local and state stakeholders. She is a professor, Family Services Research Center, department of psychiatry and behavioral sciences at the Medical University of South Carolina.

Feb. 21—Dr. Freeman A. Hrabowski III, president of the University of Maryland, Baltimore County, was described by the New York Times as “rocking the house when it comes to the increasingly critical mission of turning American college students into scientists.” A leader in math and science education, he is a champion of minority participation and achievement in science and math.

Mar. 13—Dr. Geoffrey Duyk is partner and managing director of Texas Pacific Group Ventures. He is interested in the discovery and development of small-molecule therapeutics. A former Howard Hughes Medical Institute investigator, he has served on many NIH panels and oversight committees on the planning and execution of the Human Genome Project.

Apr. 18—Dr. Miguel Nicolelis conducts studies of brain-machine interfaces with implications for refining movement of artificial limbs and is an expert in new electrophysiological techniques that record simultaneous activity of neurons in behaving animals. He is at Duke University Medical Center.

May 21—Dr. Michelle McMurry views the interface of biomedical research funding policies and health inequities from a global vantage point. A molecular immunologist and biochemist, she is now director of the Health, Biomedical Science and Society Initiative at the Aspen Institute and adjunct professor of health policy at George Washington University.

For information, call Dr. David Armstrong at (301) 443-3534. NIH Record Icon

back to top of page